Dietary Potassium Liberalization in Pre-Dialysis Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Manitoba

About this trial

The study will look at the impact of the potassium content in fruits and vegetables, on serum potassium concentrations in people with Chronic Kidney Disease (CKD) using a randomized crossover design. Participants will receive home delivery of fruit and vegetables with either higher or lower potassium content in a random order. Clinical chemistry markers from blood and urine samples, blood pressure, physical functioning and health related quality of life will be assessed throughout the duration of the trial. This study will also measure their physical functioning, using a chair stand test. The results of this study could change the dietary recommendations for people with CKD related to potassium.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female, aged 18 years or above

Participants who have an estimated glomerular filtration rate between 15 and 45 ml/min/1.73m2

Serum potassium concentration between 4.5 and 5.5 milliequivalent (mEq)/L

Hemoglobin A1c ≤ 11%

Disqualifiers

Serum potassium concentration > 5.6 mEq/L, anuria, dialysis, or acute kidney injury failure in the 6 months prior to screening

Chronic obstructive pulmonary disease that requires the participant to be on oxygen

New York Heart Association Class 3-4 Heart symptoms or heart, liver or renal transplant

A myocardial infarction or stroke within the last 6 months

Trial design

Design model

Crossover

Treatments tested in this trial

  • Liberalized dietary potassium via fruits and vegetables

    Dietary supplement

    On the liberalized dietary potassium intervention, participants will receive groceries delivered to their houses that contain potassium rich fruit and vegetables, that contain more than 250 mg of potassium per typical serving. Participants will be instructed to incorporate the fruit and vegetables into their diet targeting a daily intake of 2000 mg of potassium a day from delivered fruit and vegetables, and a daily dietary potassium intake of 3500 mg.

  • Standard dietary potassium restriction

    Dietary supplement

    Participants will receive weekly supplementation of lower potassium fruit and vegetables, that deliver less than 200 mg of potassium per typical serving. Participants will be instructed to incorporate the fruit and vegetables into their diet targeting a daily intake of 500 mg of K a day from the box, and a daily dietary K intake \< 2000 mg. Participants will receive counselling from a registered dietician (RD) to reinforce the potassium restriction.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Liberalized dietary potassium and then restricted potassium via fruit and vegetablesOther 2 interventions
Group B: Restricted dietary potassium and then liberalized potassium via fruit and vegetablesOther 2 interventions

Trial outcomes

Primary outcomes

1

Change in serum potassium concentrations between treatments

Serum potassium at the end of the liberalize dietary potassium period compared to the end of restricted dietary potassium period

Time frame
between endpoints of each experimental period (week 8 to week 16)

Secondary outcomes

1

Change in physical function related quality of life between treatments

Participants will complete the SF-12 physical component score of the Kidney Disease Quality of Life Short Form (KDQOL-SF) questionnaire.

Time frame
between endpoints of each experimental period (week 8 to week 16)
2

Change in urinary potassium between treatments

total potassium concentration in mmol/L

Time frame
between endpoints of each experimental period (week 8 to week 16)
3

Change in urinary sodium between treatments

Total sodium concentration in mmol/L

Time frame
between endpoints of each experimental period (week 8 to week 16)
4

Urinary albumin to creatinine Ratio

calculated by dividing urinary albumin concentration in milligrams by urinary creatinine concentration in grams

Time frame
between endpoints of each experimental period (week 8 to week 16)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Manitoba

Lead sponsor

Dalhousie University

Collaborator